SynthesisAnaesthesia2026
Best practice in obstetric general anaesthesia: an umbrella review of pharmacological strategies for induction of general anaesthesia.
Synthesis in Anaesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pharmacokinetic Simulation of Remifentanil Dosing at Different Effect-Site Targets During Target-Controlled Infusion for Cesarean Delivery.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGeneral anaesthesia for caesarean delivery carries specific maternal and neonatal risks. Drug choice, dose and timing during induction of general anaesthesia may influence maternal and neonatal physiology and outcomes. The objective of this umbrella review was to systematically identify, summarise and appraise evidence for pharmacological techniques for induction of general anaesthesia for caesarean delivery.
methodsDatabases were searched for eligible studies, including meta-analyses, systematic reviews, randomised controlled trials not previously synthesised and relevant observational studies. Data extraction, methodological quality assessment and evaluation of evidence certainty were conducted. Interventions were grouped into four categories: induction opioids; induction hypnotics; drugs to obtund the pressor response to laryngoscopy; and neuromuscular blocking drugs.
resultsSeven meta-analyses, two systematic reviews, 26 randomised controlled trials and 15 observational studies were included. Moderate quality evidence indicated short-acting opioids offered maternal haemodynamic benefit without negative neonatal consequences. Low quality evidence indicated propofol was associated with equivalent early neonatal resuscitation requirements compared with thiopental, but with lower risk of maternal accidental awareness during general anaesthesia. Labetalol, dexmedetomidine, lidocaine and remifentanil attenuated maternal haemodynamic response to laryngoscopy, with minimal neonatal adverse effects. Rocuronium at dose of ≥ 1 mg.kg DISCUSSION: Current evidence supports the safety of short-acting opioids, propofol as the preferred induction drug and rocuronium as a suitable alternative to suxamethonium during induction of anaesthesia for caesarean delivery. Overall, the evidence base is constrained by exclusion of high-risk pregnancies and emergency cases, thus limiting generalisability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.